An Open-label, Multi-drug, Multi-center Phase II Combination Study of AZD4635 in Patients with Prostate Cancer

Clinical Trial Grant

Duke Scholars

Principal Investigator Daniel James George Medicine, Medical Oncology

Administered By

Duke Cancer Institute

Awarded By

AstraZeneca Pharmaceuticals, LP

Start Date

June 3, 2020

End Date

April 16, 2024

Administered By

Duke Cancer Institute

Awarded By

AstraZeneca Pharmaceuticals, LP

Start Date

June 3, 2020

End Date

April 16, 2024